A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Novartis
Allist Pharmaceuticals, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Revolution Medicines, Inc.
Revolution Medicines, Inc.